Rose Dimartino - Net Worth and Insider Trading
Rose Dimartino Net Worth
The estimated net worth of Rose Dimartino is at least $69,930 dollars as of 2024-11-29. Rose Dimartino is the Director of Tekla Healthcare Opportunities Fund and owns about 1,000 shares of Tekla Healthcare Opportunities Fund (THQ) stock worth over $20,590. Rose Dimartino is the Director of abrdn Healthcare Investors and owns about 1,000 shares of abrdn Healthcare Investors (HQH) stock worth over $17,400. Rose Dimartino is also the Director of abrdn Life Sciences Investors and owns about 1,000 shares of abrdn Life Sciences Investors (HQL) stock worth over $14,130. Besides these, Rose Dimartino also holds Tekla World Healthcare Fund (THW) , Aberdeen Japan Equity Fund Inc (JEQ) . Details can be seen in Rose Dimartino's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rose Dimartino has not made any transactions after 2024-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rose Dimartino
Rose Dimartino Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rose Dimartino owns 4 companies in total, including abrdn Healthcare Investors (HQH) , abrdn Life Sciences Investors (HQL) , and Tekla Healthcare Opportunities Fund (THQ) among others .
Click here to see the complete history of Rose Dimartino’s form 4 insider trades.
Insider Ownership Summary of Rose Dimartino
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HQH | abrdn Healthcare Investors | 2024-07-16 | director |
| HQL | abrdn Life Sciences Investors | 2024-07-16 | director |
| THQ | Tekla Healthcare Opportunities Fund | 2024-07-16 | director |
 | | 2024-07-16 | director |
Rose Dimartino Latest Holdings Summary
Rose Dimartino currently owns a total of 5 stocks. Among these stocks, Rose Dimartino owns 1,000 shares of Tekla Healthcare Opportunities Fund (THQ) as of July 16, 2024, with a value of $20,590 and a weighting of 29.44%. Rose Dimartino owns 1,000 shares of abrdn Healthcare Investors (HQH) as of July 16, 2024, with a value of $17,400 and a weighting of 24.88%. Rose Dimartino also owns 1,000 shares of abrdn Life Sciences Investors (HQL) as of July 16, 2024, with a value of $14,130 and a weighting of 20.21%. The other 2 stocks Tekla World Healthcare Fund (THW) , Aberdeen Japan Equity Fund Inc (JEQ) have a combined weighting of 25.47% among all his current holdings.
Latest Holdings of Rose Dimartino
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| THQ | Tekla Healthcare Opportunities Fund | 2024-07-16 | 1,000 | 20.59 | 20,590 |
| HQH | abrdn Healthcare Investors | 2024-07-16 | 1,000 | 17.40 | 17,400 |
| HQL | abrdn Life Sciences Investors | 2024-07-16 | 1,000 | 14.13 | 14,130 |
| THW | Tekla World Healthcare Fund | 2024-07-16 | 1,000 | 12.08 | 12,080 |
| JEQ | Aberdeen Japan Equity Fund Inc | 2024-10-02 | 1,000 | 5.73 | 5,730 |
Holding Weightings of Rose Dimartino
Rose Dimartino Form 4 Trading Tracker
According to the SEC Form 4 filings, Rose Dimartino has made a total of 1 transactions in Tekla Healthcare Opportunities Fund (THQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tekla Healthcare Opportunities Fund is the acquisition of 1,000 shares on July 16, 2024, which cost Rose Dimartino around $21,300.
According to the SEC Form 4 filings, Rose Dimartino has made a total of 1 transactions in abrdn Healthcare Investors (HQH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in abrdn Healthcare Investors is the acquisition of 1,000 shares on July 16, 2024, which cost Rose Dimartino around $18,880.
According to the SEC Form 4 filings, Rose Dimartino has made a total of 1 transactions in abrdn Life Sciences Investors (HQL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in abrdn Life Sciences Investors is the acquisition of 1,000 shares on July 16, 2024, which cost Rose Dimartino around $15,530.
More details on Rose Dimartino's insider transactions can be found in the Insider Trading History of Rose Dimartino table.Insider Trading History of Rose Dimartino
- 1
Rose Dimartino Trading Performance
GuruFocus tracks the stock performance after each of Rose Dimartino's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rose Dimartino is -0.08%. GuruFocus also compares Rose Dimartino's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rose Dimartino within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rose Dimartino's insider trading performs compared to the benchmark.
Performance of Rose Dimartino
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.98 | | | | | |
| Relative Return to S&P 500(%) | 0.54 | | | | | |
Rose Dimartino Ownership Network
Rose Dimartino Owned Company Details
What does abrdn Healthcare Investors do?
Who are the key executives at abrdn Healthcare Investors?
Rose Dimartino is the director of abrdn Healthcare Investors. Other key executives at abrdn Healthcare Investors include Vice President Alan R Goodson , other: Director of Adviser Jaclyn Marie Matsick , and Chief Compliance Officer & VP Joseph Andolina .
abrdn Healthcare Investors (HQH) Insider Trades Summary
Over the past 18 months, Rose Dimartino made 1 insider transaction in abrdn Healthcare Investors (HQH) with a net purchase of 1,000. Other recent insider transactions involving abrdn Healthcare Investors (HQH) include a net purchase of 19,000 shares made by Daniel R Omstead , a net purchase of 1,000 shares made by Bill Maher , and a net purchase of 1,000 shares made by Todd Reit .
In summary, during the past 3 months, insiders sold 0 shares of abrdn Healthcare Investors (HQH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of abrdn Healthcare Investors (HQH) were sold and 22,695 shares were bought by its insiders, resulting in a net purchase of 22,695 shares.
abrdn Healthcare Investors (HQH)'s detailed insider trading history can be found in Insider Trading Tracker table.
abrdn Healthcare Investors Insider Transactions
Rose Dimartino Mailing Address
Above is the net worth, insider trading, and ownership report for Rose Dimartino. You might contact Rose Dimartino via mailing address: C/o Abrdn, 1900 Market Street, Philadelphia Pa 19103.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
